A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PEA / beta-phenylethylamine

[Related PubMed/MEDLINE]
Total Number of Papers: 304
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PEA  (>> Co-occurring Abbreviation)
Long Form:   beta-phenylethylamine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Simultaneous determination of beta-agonists on hexagonal boron nitride nanosheets/multi-walled carbon nanotubes nanocomposite modified glassy carbon electrode. AA, CLE, CV, EIS, f-MWCNTs, GCE, LOD, RAC, SAL, SEM, UA, XRD
2018 A sensitive, high-throughput LC-MS/MS method for measuring catecholamines in low volume serum. EPI, MN, MRM, NE, NMN, PITC
2018 Air-Stable and Self-Driven Perovskite Photodiodes with High On/Off Ratio and Swift Photoresponse. DMSO, RP
2018 Cell-Based Biosensor with Dual Signal Outputs for Simultaneous Quantification of Phenylacetic Acid and Phenylethylamine. PA
2018 Efficacy of beta-phenylethylamine as a novel anti-microbial and application as a liquid catheter flush. ATP
2018 Non-adrenergic vasoconstriction and vasodilatation of guinea-pig aorta by beta-phenylethylamine and amphetamine - Role of nitric oxide determined with L-NAME and NO scavengers. L-NAME, NO, TAAR
2018 Why does the Y326I mutant of monoamine oxidase B decompose an endogenous amphetamine at a slower rate than the wild type enzyme? Reaction step elucidated by multiscale molecular simulations. MAO-B
2017 A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain. BPAP, CAE, DEP, TMS, VMAT2
2017 Accumulation and Determination of Phenylethanolamine A Residue in Hair of Swine and Sheep. ---
10  2017 Biosensor for the characterisation of hMAO B inhibitors and the quantification of selegiline. FIA, hMAO-B
11  2017 Multiscale simulation of monoamine oxidase catalyzed decomposition of phenylethylamine analogs. EVB, MAO, p-CMP, p-MMP
12  2017 The Effect of Experimental Supplementation with the Klamath Algae Extract Klamin on Attention-Deficit/Hyperactivity Disorder. ADHD
13  2016 Conformational distortion of alpha-phenylethyl amine in cryogenic matrices - a matrix isolation VCD study. PES, VCD
14  2016 Nuclear spatial delocalization silences electron density oscillations in 2-phenyl-ethyl-amine (PEA) and 2-phenylethyl-N,N-dimethylamine (PENNA) cations. PENNA
15  2016 Olsalazine-Based Metal-Organic Frameworks as Biocompatible Platforms for H2 Adsorption and Drug Delivery. ---
16  2016 Publisher's Note: "Nuclear spatial delocalization silences electron density oscillations in 2-phenyl-ethyl-amine (PEA) and 2-phenylethyl-N,N-dimethylamine (PENNA) cations" [J. Chem. Phys. 144, 104110 (2016)]. PENNA
17  2016 The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015). CAE, DEP
18  2015 A beating heart cell model to predict cardiotoxicity: effects of the dietary supplement ingredients higenamine, phenylethylamine, ephedrine and caffeine. bpm
19  2015 A monoclonal antibody based enzyme-linked immunosorbent assay for detection of phenylethanolamine A in tissue of swine. cBSA, ELISA, McAb
20  2015 Amino acid conversions by coagulase-negative staphylococci in a rich medium: Assessment of inter- and intraspecies heterogeneity. CNS, SH-GC-MS
21  2015 Aspergillus oryzae pathways that convert phenylalanine into the flavor volatile 2-phenylethanol. AadA, PE
22  2015 Behavioral effects of beta-phenylethylamine and various monomethylated and monohalogenated analogs in mice are mediated by catecholaminergic mechanisms. ---
23  2015 Revealing Monoamine Oxidase B Catalytic Mechanisms by Means of the Quantum Chemical Cluster Approach. BA, MAO-B, NBA
24  2015 Superparamagnetic core-shells anchored onto graphene oxide grafted with phenylethyl amine as a nano-adsorbent for extraction and enrichment of organophosphorus pesticides from fruit, vegetable and water samples. FTIR, GC-NPD, GO, MSPE, OPPs, RSDs, SEM, VSM
25  2014 Analgesic effects of beta-phenylethylamine and various methylated derivatives in mice. ---
26  2014 LC-MS-MS analysis of dietary supplements for N-ethyl-alpha-ethyl-phenethylamine (ETH), N, N-diethylphenethylamine and phenethylamine. ETH, LC-MS-MS, WADA
27  2014 Modulation of resistance artery tone by the trace amine beta-phenylethylamine: dual indirect sympathomimetic and alpha1-adrenoceptor blocking actions. ---
28  2014 ss-Phenylethylamine as a novel nutrient treatment to reduce bacterial contamination due to Escherichia coli O157:H7 on beef meat. AAA
29  2013 beta-phenylethylamine, a small molecule with a large impact. ---
30  2013 Coupled electron-nuclear dynamics: charge migration and charge transfer initiated near a conical intersection. ---
31  2013 Effect of fluazifop-p-butyl treatment on pigments and polyamines level within tissues of non-target maize plants. ACCase, ANC, FL, LDC, ODC, TYDC
32  2013 Enantiomeric fraction determination of 2-arylpropionic acids in a package plant membrane bioreactor. 2-APA, EFs, MBR
33  2013 New phenethylamine derivatives from Arenibacter nanhaiticus sp. nov. NH36A(T) and their antimicrobial activity. ---
34  2013 Relative quantification of enantiomers of chiral amines by high-throughput LC-ESI-MS/MS using isotopic variants of light and heavy L-pyroglutamic acids as the derivatization reagents. L-PGA, MRM
35  2013 [Localization and functions of the D-neuron: significance in pathogenesis of schizophrenia]. AADC, DA, LSD, MDMA, TAAR1, TAs, VTA
36  2012 Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. ADHD, DHEA, HPA, MAO, MHPG, NE, NPY, Zn
37  2012 Effects of fluorine substitution on the shape of neurotransmitters: the rotational spectrum of 2-(2-fluorophenyl)ethanamine. ---
38  2012 Immobilization of Escherichia coli containing omega-transaminase activity in LentiKats. Ala, APB, CTAB, IPA, omega-TA
39  2012 Tyramine and phenylethylamine biosynthesis by food bacteria. PLP, TDC
40  2011 Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. MAO
41  2011 Conformational equilibrium and hydrogen bonding in liquid 2-phenylethylamine explored by Raman spectroscopy and theoretical calculations. ---
42  2011 Detection of the reaction intermediates catalyzed by a copper amine oxidase. AGAO
43  2011 Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists. ADRB1, GPCR, OA, TAAR, TAR, TYR
44  2010 2-Phenylethylamine, a constituent of chocolate and wine, causes mitochondrial complex-I inhibition, generation of hydroxyl radicals and depletion of striatal biogenic amines leading to psycho-motor dysfunctions in Balb/c mice. ---
45  2010 A 4-hydroxy-N'-[(E)-(2-hydroxyphenyl)methylidene]benzohydrazide-based sorbent material for the extraction-HPLC determination of biogenic amines in food samples. BAs, Cad, HIS, Put, Spd, TRY, TYR
46  2010 Selective electrochemical discrimination between dopamine and phenethylamine-derived psychotropic drugs using electrodes modified with an acyclic receptor containing two terminal 3-alkoxy-5-nitroindazole rings. AMPH, DA, HOM, MES, METH, PMA
47  2010 Transport of phenylethylamine at intestinal epithelial (Caco-2) cells: mechanism and substrate specificity. ---
48  2009 A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. ---
49  2009 Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. KO, MAO, TAAR1, WT
50  2009 Intramolecular interactions of L-phenylalanine revealed by inner shell chemical shift. PPA
51  2008 Chiral mono and diamide derivatives of calix[4]arene for enantiomeric recognition of chiral amines. ---
52  2008 Escherichia coli NsrR regulates a pathway for the oxidation of 3-nitrotyramine to 4-hydroxy-3-nitrophenylacetate. NO
53  2008 [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508]. CAR
54  2007 Comparative study of charge division in substituted benzene cations. PB, PEAL, PPA
55  2007 Conformational study of tyramine and its water clusters by laser spectroscopy. ---
56  2007 Simultaneous determination of 13 amphetamine related drugs in human whole blood using an enhanced polymer column and gas chromatography-mass spectrometry. MA, MDA, MDMA, ME, PMA
57  2007 Synthesis, structures, and optical properties of cadmium iodide/phenethylamine hybrid materials with controlled structures and emissions. CdI2
58  2007 Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. AMPH, HEK, METH, mTAAR1, p-OHA, rTAAR1, TAs, TYR
59  2007 Trace amine-associated receptor 1-Family archetype or iconoclast? AMPH, cAMP, DA, GPCR, OCT, SYN, TA, TAAR, TAR1, Tryp, TYR
60  2006 Simultaneous liquid chromatography determination of polyamines and arylalkyl monoamines. DA, DAP, Put, SAL, Spd, Spm, TYR
61  2005 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice. ---
62  2005 A rapid, sensitive electron-capture gas chromatographic procedure for analysis of metabolites of N-methyl,N-propargylphenylethylamine, a potential neuroprotective agent. MPPE, N-methylPEA, N-propargylPEA, PFBSC
63  2005 Experimental and modelization approach in the study of acid-site energy distribution by base desorption. Part I: modified silica surfaces. TGA
64  2005 Primate trace amine receptor 1 modulation by the dopamine transporter. MDMA
65  2004 Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. DA, NE
66  2004 Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery. 5-HIAA, MAO
67  2004 Pharmacological studies with endogenous enhancer substances: beta-phenylethylamine, tryptamine, and their synthetic derivatives. MAO, TAs
68  2004 Significance of human striatal D-neurons: implications in neuropsychiatric functions. AADC, ACC
69  2003 A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition. 5-HIAA, AMT, DMS, GC-MS, GLC, HPLC, MAO-A, MAO-B, MET
70  2003 An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug. 5-HT, MAO, MAO-A, RIZ
71  2003 Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets. 5-HT, IAA, IBA, TRP, TYR
72  2003 Seasonal changes in plasma concentrations of cecum-derived amines in clinically normal ponies and ponies predisposed to laminitis. HPLC, IAA, TRP, TYR
73  2003 Semicarbazide-sensitive amine oxidases in pig dental pulp. 5-HT, SSAO
74  2002 1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged. ---
75  2002 Diastereomeric salts of lactic acid and 1-phenylethylamine, their structures and relative stabilities. S-LA, S-LA
76  2002 Monoamine-dependent production of reactive oxygen species catalyzed by pseudoperoxidase activity of human hemoglobin. Hb, ROS
77  2002 Phenylethylamine induces an increase in cytosolic Ca2+ in yeast. ---
78  2002 Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease. MAO
79  2002 [Decreased beta-phenylethylamine in urine of children with attention deficit hyperactivity disorder and autistic disorder]. 5-HIAA, AD, ADHD, HVA, MHPG
80  2002 [Human striatal D-neurons and their significance]. AADC, DA, NA, TH, TPH
81  2002 [Localization of non-monoaminergic aromatic L-amino acid decarboxylase neurons (D-neurons) in the human striatum and their functional significance]. AADC, D-neurons, D-neurons
82  2002 [Neuroimaging and neurochemical studies of Rett syndrome]. MeCP2, RTT
83  2001 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity. MAO
84  2001 Apical dominance in Pssu-ipt-transformed tobacco. AAs, CKs, PA, Put, Spd, Spm, TYR
85  2001 Application of automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the measurement of enzyme activities. EMA, GC, MALDI-TOF MS, MET
86  2001 Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug. ---
87  2001 Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease. GC-MS, MAO-B
88  2001 Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. CAE/SAE
89  2000 Aromatic monoamine-induced immediate oxidative burst leading to an increase in cytosolic Ca2+ concentration in tobacco suspension culture. AOS
90  2000 Decreased cerebrospinal fluid levels of beta-phenylethylamine in patients with Rett syndrome. ---
91  2000 Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells. CHO, DA, DTT, L-DOPA
92  2000 Effects of beta-phenylethylamine on the hypothalamo-pituitary-adrenal axis in the male rat. ACTH, CRH, HPA, ME
93  2000 Phenylethylamine-induced generation of reactive oxygen species and ascorbate free radicals in tobacco suspension culture: mechanism for oxidative burst mediating Ca2+ influx. AOS, HRP, MDA
94  2000 Plasma beta-phenylethylamine in Parkinson's disease. PD
95  2000 Quantitation of low molecular mass substrates and products of enzyme catalyzed reactions using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. BzA, MET
96  1999 (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. ---
97  1999 Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction. 1MeTIQ, MPTP
98  1999 Cerebral cortical blood flow maps are reorganized in MAOB-deficient mice. CBF, MAO-B
99  1999 Developmental aspects of cerebrospinal fluid levels of beta-phenylethylamine and it's role in pediatric neurological disorders. CSF, RS
100  1999 Role of MAO A and B in neurotransmitter metabolism and behavior. DA, KO, MAO, NE